Business

CardioComm Solutions Launches GEMS(TM) WIN and HeartCheck(TM) Direct Sales Force to Expand Access to USA Hospital and Physician Markets

TORONTO, ON / ACCESSWIRE / November 15, 2016 / CardioComm Solutions, Inc. (TSXV: EKG) ("Card...

articleCardiocomm Solutions, Inc.November 15, 20164/company/cardiocomm-solutions-inc/news/cardiocomm-solutions-launches-gemstm-win-and-heartchecktm-direct-sales-force-to-expand-access-to-usa-hospital-and-physician-markets
CardioComm Solutions Launches GEMS(TM) WIN and HeartCheck(TM) Direct Sales Force to Expand Access to USA Hospital and Physician Markets

About this update from Cardiocomm Solutions, Inc.

[{"type":"text","content":"CardioComm Solutions Launches GEMS(TM) WIN and HeartCheck(TM) Direct Sales Force to Expand Access to USA Hospital and Physician MarketsTORONTO, ON / ACCESSWIRE / November 15, 2016 / CardioComm Solutions, Inc. (TSXV: EKG) (\"CardioComm Solutions\" or the \"Company\"), a global medical provider of consumer heart monitoring and medical electrocardiogram (\"ECG\") software solutions, today announced it has entered into a three year agreement for sales of the Company's Global ECG Management Software (GEMS™ WIN), handheld HeartCheck™ ECG devices and SMART Monitoring ECG services into physician practices, pharmacies and hospital markets in the United States of America (\"USA\").\nThe CardioComm Solutions' USA sales program (the \"Representative\") will utilize a network of channel partners and sales representatives that are already actively selling medical devices into the healthcare market. The CardioComm products have been identified as being of particular interest as there is a growing need for the introduction of reliable new and emerging ECG monitoring solutions to provide additional physician billing opportunities. Similar opportunities exist in the allied health markets, such as pharmacy banner groups, which will also be targeted by the Representative.\nWhat is unique about CardioComm Solutions' HeartCheck™ and GEMS™ WIN products is that all are cleared for sale and use as Class II medical devices in the USA. This allows for the CardioComm Solutions' products to be used in reimbursable medical services by healthcare providers and health service organizations. Services supported include long-term ECG monitoring such as mobile cardiac telemetry, arrhythmia and prolonged QT interval screening/monitoring as an extention to in-hospital and in-clinic services as well as supporting long-term managed care support for people living with chronic medical conditions. Under the agreement, CardioComm Solutions will provide training of the Representative's sales force and for supporting new customer installations.\nManaged by a central sales manager, the Representative's syndicate of channel partners will work towards annual revenue targets and be provided fees exclusively on a success basis. Fees will be provided under a standard commission structure as well as an inducement of share options. Under the inducement, ...

More updates from Cardiocomm Solutions, Inc.